This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Giles, T. D. Articles by Sander, G. E. Search for Related Content PubMed PubMed Citation Articles by Giles, T. D. Articles by Sander, G. E. Social Bookmarking                         What's this?

Acute and Short-Term Effects of Clonidine in Heart Failure

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

Madaelil G. Thomas

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

Antonio C. Quiroz

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

Janet C. Rice

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

Wade Plauche

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

Gary E. Sander

Department of Medicine, Tulane University School of Medicine and Veterans Administration Medical Center, New Orleans, Louisiana

The authors performed a randomized, double-blind, placebo-controlled trial to assess the tolerance and effects of chronic oral clonidine administration on the clinical status, exercise tolerance, and ventricular function of 10 male patients with chronic heart failure. Patients were given either oral clonidine (400 µg/day) or matching placebo for twelve weeks and then tapered off medication over a two-week period.

Results are summarized as follows: Profiles over time between groups were significantly different for resting heart rate (p = 0.0005), were different for arterial pressure (p=0.04), were different for left ventricular ejection fraction (p < 0.006), and were different for mean accumulated workload (p=0.076).

Exercise double product at 25 watts changed little in three patients and showed a decrease in 2 patients following six weeks of oral clonidine; after twelve weeks, it decreased in three patients, increased in 1, and changed little in another. After washout, double product returned toward baseline values. In the placebo groups, double product showed little change.

Resting of the heart by decreasing heart rate, systemic arterial blood pressure, and venous tone are thought by the authors to be major contributing factors to the observed beneficial effect of chronic oral clonidine in chronic heart failure.

Angiology, Vol. 38, No. 7, 537-548 (1987)
DOI: 10.1177/000331978703800707


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Swedberg, C.-H.a. Bergh, K. Dickstein, J. McNay, M. Steinberg, and Moxonidine Investigators The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure J. Am. Coll. Cardiol., February 1, 2000; 35(2): 398 - 404. [Abstract] [Full Text] [PDF]

				C. C. Lang, C. M. Stein, R. A. Nelson, H. B. He, F. J. Belas, I. A. Blair, M. Wood, and A. J. J. Wood Sympathoinhibitory Response to Clonidine Is Blunted in Patients With Heart Failure Hypertension, September 1, 1997; 30(3): 392 - 397. [Abstract] [Full Text]